| |
Sonablate
System Information
Operations
Results
Users
Clinical Publications
THS
International
Home
Distribution
Information
Contact Information |
|
SONABLATE® 500
Clinical Publications
The following list is a short
summary of some of the recent and indicative publications and
presentations on the advanced Sonablate® 500 HIFU
system. For more information or a more complete listing please
contact
info@thsinternational.com .
Clinical Efficacy & Outcomes
 T.
Uchida, M. Nitta, S. Hongo, S. Shoji, Y. Nagata, Y. Usui, T.
Terachi, Tokyo University Hachioji Hospital - Tokai University,
Tokyo, Japan,
"High
Intensity Focused Ultrasound For The Treatment In 517 Patients
With Localized Prostate Cancer",
Presented at the 29th SIU-Congress, Paris, France September 2007.
M.
Emberton, R. Illing, T. Leslie, J. Kennedy, J. Calleary, C.
Ogden, Institute of Urology and Nephrology, University College
London, London, England,
“Visually directed high-intensity focused
ultrasound for organ-confined prostate cancer: a proposed
standard for the conduct of therapy”,
British Journal of Urology, July, 2006.
Long term Efficacy
8
Year Follow-Up: T.
Uchida, M. Nitta, S. Hongo, S. Shoji, Y. Nagata, Y. Usui, T. Terachi, Tokyo
University Hachioji Hospital - Tokai University,
Tokyo, Japan,
"High
Intensity Focused Ultrasound For The Treatment In 517 Patients With Localized Prostate Cancer",
Presented at the 29th SIU-Congress, Paris, France September 2007.
T. Uchida, H. Yamashita, H. Ohkusa and Y. Nagata,
"Clinical Outcome of HIFU for the Treatment of
Localized Prostate Cancer: 5-Year Experience",
presented at the
International Symposium on Therapeutic Ultrasound, Boston,
Massachusetts, September, 2004.
Quality of Life and Complication Rates
T.
Uchida, e. Yamashita, Y. Okusa, T. Nagat, Tokai University
Hachioji Hospital, Tokyo, Japan,
“Quality of life in patients with
high-intensity focused ultrasound (HIFU) for localized prostate
cancer”, poster presentation at Japan
Endourology & ESWL Conference, Okayama, Japan, November, 2004.
Salvage HIFU Applications
M.Emberton, E.
Zacharakis, H. Ahmend, A. Ishaq, R. Scott, R. Illing, A.
Freeman, C. Allen, University College London Hospitals, London,
England,
“The feasibility and
safety of high-intensity focused ultrasound as salvage therapy
for recurrent prostate cancer following external beam
radiotherapy”, British Journal of Urology, March
2008.
M.
Hayashi, T. Asano, T. Uchida, Tokai University Hachioji
Hospital, Tokyo, Japan,
“Experience of transrectal high-intensity
focused ultrasound for treatment of patients with biochemical
failure after radical prostatectomy”,
poster presentation at Japan Endourology & ESWL Conference,
Tokyo, Japan, November, 2007.
Explanation of the
Technology and Advanced Features
M.
Emberton, R. Illing, University College Hospitals London,
London, England,
“Sonablate® 500: transrectal
high-intensity focused ultrasound for the treatment of prostate
cancer”, Expert Review Medical Devices
3(6), 717-729 (2006).
T.
Gardner, M. Koch, Indiana University Medical Center,
Indianapolis, Indiana,
“Prostate cancer therapy with
high-intensity focused ultrasound”,
Clinical Genitourinary Cancer, Vol. 4, No. 3, 187-192, 2005.
Future Uses of Sonablate®
500 HIFU Technology
M. Marberger,
H.C. Klinger, M. Susani, R. Seip, J. Mauermann, N. Sanghvi,
University of Vienna Medical College, Vienna, Austria,
“A novel approach to energy ablative
therapy of small renal tumours: laparoscopic high-intensity
focused ultrasound”, European Association of Urology
Journal, November, 2007.
|
|